yao xue jin zhan

..............page:797

lin chuang yao xue : ju jiao ge ti hua yong yao
zhou guo hua ;

..............page:801-802

Application of Pharmacogenomics in Clinical Trials of New Drugs and Individualized Administration
GENG Chunmei;GUO Ruichen;Institute of Clinical Pharmacology;Qilu Hospital of Shandong University;

..............page:803-809

yao xue jin zhan 2016 nian zheng ding qi shi

..............page:809

Advances in Research on Pharmacokinetics/Pharmacodynamics of Posaconazole and Its Therapeutic Drug Monitoring
CHEN Lu;WANG Taotao;DONG Yalin;Department of Pharmacy;the First Affiliated Hospital of Xi’an Jiaotong University;

..............page:810-816

Research Progress in the Correlation between ABCB1, CES1 and CYP2C19 Gene Polymorphisms and Clopidogrel Resistance
LI Jiaxin;LIU Kaixuan;LI Yan;GAO Jie;ZHANG Yujia;ZOU Jianjun;School of Pharmacy;China Pharmaceutical University;Clinical Pharmacology Laboratory;Nanjing Hospital Affiliated to Nanjing Medical University;

..............page:817-822

Discussion on Risk Management in New Drug Development from the Perspective of U.S. FDA Review
GONG Zhaolong;DU Tao;3D Medicines Inc.;Humphries Pharmaceutical Consulting;LLC;

..............page:823-826

zhong guo yao xue nian jian 2014 juan zheng ding qi shi

..............page:826

Discussion on the Similarities and Dif erences between Drug Review Systems in China and the U.S.A from the View of Innovative Drug Application
ZHU Bin;ZHAO Zhigang;Department of Pharmacy;Beijing Tian Tan Hospital;Capital Medical University;

..............page:827-831

Analysis and Research on the Biopharm Industry of Changzhou in 2014
CHEN Rui;CHEN Yao;WENG Jianhong;XIE Shujiang;JIANG Pengju;Changzhou Biotechnology Development Center;Changzhou Popularization of Science & Technology Service Center;Changzhou Science & Technology Bureau;Changzhou University;

..............page:832-837

Research Progress in Acidic Sphingomyelinase/Ceramide Pathway: Its Role and Mechanism in Development of Related Diseases
ZHANG Kuojun;GU Qinlan;WANG Minghui;ZHAO Li;YANG Kan;WANG Jinxin;Key Laboratory of Drug Design and Optimization of Jiangsu Provinve;China Pharmaceutical University;Altitude Vocational School;China Pharmaceutical University;Department of Physiology;China Pharmaceutical University;

..............page:838-845

Research Progress on Invasive Reaction-based Gene Mutation Detection Methods
ZOU Bingjie;ZHOU Guohua;SONG Qinxin;Department of Pharmacology;Nanjing General Hospital of Nanjing Military Command;Key Laboratory of Drug Quality Control and Pharmacovigilance of Ministry of Education;China Pharmaceutical University;Department of Pharmaceutical Analysis;China Pharmaceutical University;

..............page:846-854

kan wu

..............page:854

World Preview 2015, Outlook to 2020(Ⅳ)
Evaluate Pharma;

..............page:855-869

Analysis of Global Hot Drug Targets in 2014 —— IL-6-targeted Drugs
LIU Lili;MAO Yanyan;GAO Liubin;Intelligence Research Department;Information Center;Shanghai Institute of Materia Medica Chinese Academy of Sciences;

..............page:870-873

An Overview of New Drugs Approved in the US, EU and Japan in November 2015
SUN Yousong;

..............page:874-880